#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	1228	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1377	47.6	0	.	p	.	0	K29T	NONSYN	85	87	AAG	448	450	ACG	78;73;73	A;C;G	76;73;73	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	167	3846	Escherichia_coli_EF_Tu	1185	1165	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1165	148.7	0	HET	.	.	.	C954T	.	954	954	C	953	953	C	149	C,T	88,60	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	167	3846	Escherichia_coli_EF_Tu	1185	1165	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1165	148.7	0	HET	.	.	.	T135C	.	135	135	T	134	134	T	106	T,C	63,36	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	167	3846	Escherichia_coli_EF_Tu	1185	1165	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1165	148.7	0	HET	.	.	.	C216T	.	216	216	C	215	215	C	122	C,T	77,42	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	167	3846	Escherichia_coli_EF_Tu	1185	72	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.5	371	21.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1952	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1956	53.6	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1649	1651	AAA	40;40;40	A;A;A	40;40;40	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	2122	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1833	61.9	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1294	1296	GAA	87;87;90	G;A;A	87;87;90	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	638	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	1005	33.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	287	G	207	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	299	T	218	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	260	G	256	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	246	C	243	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	234	C	233	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	262	T	261	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	287	C	285	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	201	C	201	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	213	A	213	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	209	A	209	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	209	A	209	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	199	T	198	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	194	C,A	193,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	202	C	201	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	203	A	203	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	197	G	197	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	197	C	197	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	214	T	213	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	289	G	287	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	299	G	299	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	310	T	310	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	277	T	275	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	259	G	259	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	189	C	187	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	186	A	185	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	175	C	174	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	165	C	164	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	67	A	66	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	65	A	65	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	60	G	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	60	C	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	140	T	139	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	152	G	152	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	157	T	156	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	320	C	316	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	6282	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.2	866	182.2	0	HET	.	.	.	T1040C	.	1040	1040	T	15	15	T	256	T,C	91,85	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1738	PmrB_1	1092	1092	99.08	PmrB_1.l6.c30.ctg.1	1641	56.4	0	.	p	.	0	H2R	NONSYN	4	6	CAT	275	277	CGT	46;47;50	C;G;T	46;47;50	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1738	PmrB_1	1092	1092	99.08	PmrB_1.l6.c30.ctg.1	1641	56.4	0	.	p	.	0	V30I	NONSYN	88	90	GTC	359	361	ATC	76;75;76	A;T;C	76;75;76	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1738	PmrB_1	1092	1092	99.08	PmrB_1.l6.c30.ctg.1	1641	56.4	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1118	1120	GGC	62;61;61	G;G;C	62;61;61	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2618	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2178	64.4	0	.	p	.	0	R8S	NONSYN	22	24	AGA	289	291	AGC	51;50;51	A;G;C	49;49;51	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2618	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2178	64.4	0	.	p	.	0	I142L	NONSYN	424	426	ATA	691	693	CTA	66;66;64	C;T;A	66;65;64	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2618	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2178	64.4	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1210	1212	CAA	72;76;76	C;A;A	71;75;75	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2618	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2178	64.4	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1309	1311	GGT	76;77;76	G;G,A;T	76;76,1;76	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2618	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2178	64.4	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1879	1881	GTT	43;42;40	G;T;T	43;42;40	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1254	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1849	36.5	0	.	p	.	0	A125E	NONSYN	373	375	GCA	744	746	GAA	53;54;54	G;A;A	53;54;54	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1254	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1849	36.5	0	.	p	.	0	M185T	NONSYN	553	555	ATG	924	926	ACC	31;31;30	A;C;C	31;31;30	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1254	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1849	36.5	0	.	p	.	0	S225T	NONSYN	673	675	TCC	1044	1046	ACT	30;30;29	A;C;T	30;30;29	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1254	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1849	36.5	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1434	1436	ATC	30;31;30	A;T;C	30;31;30	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	1548	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1656	50.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	1452	aad-	789	789	100.0	aad-.l6.c30.ctg.1	1474	52.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	4174	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3667	61.0	0	.	p	.	0	T85I	NONSYN	253	255	ACC	571	573	ATC	84;81;81	A;T;C	84;81;81	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	4174	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3667	61.0	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2284	2286	AAG	57;57;54	A;A;G	57;57;54	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1638	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1862	47.2	0	.	p	.	0	A22V	NONSYN	64	66	GCC	401	403	GTC	31;32;32	G;T;C	31;32;32	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1638	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1862	47.2	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1142	1144	TGC	78;79;79	T;G;C	78;79;79	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3944	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3239	64.9	0	.	p	.	0	S46trunc	TRUNC	136	136	T	457	457	T	49	T	49	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3944	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3239	64.9	0	.	p	.	0	G148D	NONSYN	442	444	GGC	763	765	GAC	83;76;77	G;A;C	83;76;77	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3944	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3239	64.9	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1039	1041	TTA	51;50;49	T;T;A	51;50;49	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3944	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3239	64.9	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1222	1224	AAT	64;64;64	A;A;T	64;64;63	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3944	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3239	64.9	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	2009	2009	T	88	T	87	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	1220	acrR_2	648	648	99.54	acrR_2.l6.c30.ctg.1	1152	56.6	1	SNP	p	R45C	0	.	.	133	135	CGC	418	420	CGC	81;82;85	C;G;C	81;81;84	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	974	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1249	41.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	413	415	TTC	32;31;31	T;T;C	32;31;30	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	974	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1249	41.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	677	679	GGG	75;74;72	G,C;G;G	74,1;74;72	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	1442	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1475	52.4	0	.	p	.	0	V136L	NONSYN	406	408	GTT	748	750	CTT	95;93;92	C;T;T	94;92;92	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3390	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3215	56.4	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2093	2095	GCA	60;61;64	G;C;A	60;61;64	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3390	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3215	56.4	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2354	2356	ACC	57;55;55	A;C;C	57;54;55	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3390	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3215	56.4	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2663	2665	GCC	47;46;48	G;C;C	47;46;48	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2304	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2556	48.2	0	.	p	.	0	G37A	NONSYN	109	111	GGT	346	348	GCT	22;23;23	G;C;T	22;23;23	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2304	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2556	48.2	0	.	p	.	0	D77E	NONSYN	229	231	GAT	466	468	GAG	26;26;25	G;A;G	26;26;25	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2304	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2556	48.2	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	502	504	TGC	27;27;28	T;G;C	27;27;28	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2304	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2556	48.2	0	.	p	.	0	I150V	NONSYN	448	450	ATT	685	687	GTT	42;42;43	G;T;T	41;42;43	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2304	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2556	48.2	0	.	p	.	0	R200H	NONSYN	598	600	CGC	835	837	CAC	49;48;41	C;A;C	48;48;41	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2304	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2556	48.2	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1120	1122	ATG	60;60;60	A;T;G	59;58;59	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2304	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2556	48.2	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2116	2118	CGC	41;41;42	C;G;C	41;41;42	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	1106	bacA	822	822	98.54	bacA.l6.c30.ctg.1	1436	41.2	0	.	p	.	0	S221T	NONSYN	661	663	AGC	952	954	ACC	31;31;31	A;C;C	31;31;31	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	1106	bacA	822	822	98.54	bacA.l6.c30.ctg.1	1436	41.2	0	.	p	.	0	P225S	NONSYN	673	675	CCG	964	966	TCG	38;39;41	T;C;G	38;38;41	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	864	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1286	35.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1604	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2104	40.9	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1474	1476	AAA	40;41;42	A;A;A	38;40;42	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1604	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2104	40.9	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1486	1488	GAG	40;39;41	G;A;G	40;36;41	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1604	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2104	40.9	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1492	1494	CAC	44;44;45	C;A;C	44;43;45	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1604	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2104	40.9	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1546	1548	GAG	43;43;43	G;A;G	43;43;43	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1866	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1963	51.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	1328	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1336	53.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	1374	cysB	975	975	99.28	cysB.l6.c30.ctg.1	1681	43.9	0	.	p	.	0	A146T	NONSYN	436	438	GCT	744	746	ACT	74;72;72	A;C;T	74;72;72	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	1	0	27	966	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	1104	47.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1574	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1847	45.8	0	.	p	.	0	I219V	NONSYN	655	657	ATC	1017	1019	GTC	60;59;59	G;T;C	60;58;58	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	2414	emrB	1539	1539	99.74	emrB.l15.c30.ctg.1	2159	60.0	0	.	p	.	0	E197K	NONSYN	589	591	GAA	919	921	AAA	60;62;63	A;A;A	60;61;61	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1478	emrD	1191	1191	98.4	emrD.l6.c30.ctg.1	1870	42.3	0	.	p	.	0	G209S	NONSYN	625	627	GGC	942	944	AGC	50;48;49	A;G;C	50;48;49	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	513	78	emrE_1	333	189	91.53	emrE_1.l6.c4.ctg.1	192	5.2	0	.	p	.	0	I100V	NONSYN	298	300	ATT	169	171	GTC	2;2;2	G;T;C	2;2;2	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	513	78	emrE_1	333	95	96.84	emrE_1.l6.c4.ctg.2	343	8.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1478	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1603	49.4	0	.	p	.	0	K176R	NONSYN	526	528	AAG	792	794	AGG	40;40;43	A;G;G	40;40;43	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1478	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1603	49.4	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1182	1184	GAC	43;43;42	G;A;C	43;43;42	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	960	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1135	45.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	2366	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	2049	61.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	922	evgA	615	615	99.19	evgA.l6.c30.ctg.1	1246	39.6	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	504	506	CTG	58;59;60	C;T;G	58;59;60	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	T38I	NONSYN	112	114	ACA	472	474	ATA	28;28;25	A;T;A	28;28;25	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	L42V	NONSYN	124	126	CTA	484	486	GTA	26;26;26	G;T;A	25;26;26	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	A93T	NONSYN	277	279	GCG	637	639	ACG	42;43;46	A;C;G	42;43;46	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	A114E	NONSYN	340	342	GCA	700	702	GAA	39;38;38	G;A;A	39;38;38	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	T127A	NONSYN	379	381	ACT	739	741	GCT	39;39;37	G;C;T	39;39;37	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	N133D	NONSYN	397	399	AAT	757	759	GAT	41;43;43	G;A;T	41;43;43	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	P162S	NONSYN	484	486	CCA	844	846	TCA	35;36;36	T;C;A	35;36;36	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	973	975	CAG	30;30;27	C;A;G	30;29;27	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1111	1113	GTT	40;38;39	G;T;T	40;38;39	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1267	1269	GAT	28;28;27	G;A;T	28;28;27	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1435	1437	AAT	44;44;43	A;A;T	44;44;43	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1456	1458	TTA	28;28;28	T;T;A	28;28;28	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1657	1659	AAA	29;28;28	A;A;A	29;28;28	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2392	2394	CAT	65;64;61	C;A;T	65;64;61	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2446	2448	CAT	45;47;48	C;A;T	45;47;48	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2464	2466	AGA	47;49;49	A;G;A	47;49;49	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2479	2481	AAT	53;56;55	A;A;T	53;56;55	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2626	2628	TCC	38;40;41	T;C;C	38;40;41	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2791	2793	ATT	52;51;44	A;T;T	52;51;44	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2812	2814	GAT	53;55;56	G;A;T	53;55;56	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2926	2928	GTT	53;54;55	G;T;T	53;54;54	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4428	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4222	56.3	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3211	3213	CAC	68;69;68	C;A;C	67;67;67	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1366	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1366	53.5	1	SNP	p	P64L	0	.	.	190	192	CCA	492	494	CCA	95;95;101	C;C;A	95;94;93	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1366	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1366	53.5	1	SNP	p	P64R	0	.	.	190	192	CCA	492	494	CCA	95;95;101	C;C;A	95;94;93	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1366	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1366	53.5	1	SNP	p	P64A	0	.	.	190	192	CCA	492	494	CCA	95;95;101	C;C;A	95;94;93	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1366	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1366	53.5	1	SNP	p	P64H	0	.	.	190	192	CCA	492	494	CCA	95;95;101	C;C;A	95;94;93	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1366	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1366	53.5	1	SNP	p	P64S	0	.	.	190	192	CCA	492	494	CCA	95;95;101	C;C;A	95;94;93	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	1052	gadE	528	528	100.0	gadE.l15.c30.ctg.1	1106	50.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	264	gadW	729	722	94.32	gadW.l6.c30.ctg.1	848	16.5	0	.	p	.	0	V10I	NONSYN	28	30	GTT	21	23	ATT	3;3;3	A;T;T	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	264	gadW	729	722	94.32	gadW.l6.c30.ctg.1	848	16.5	0	.	p	.	0	H17Y	NONSYN	49	51	CAT	42	44	TAT	4;3;3	T;A;T	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	264	gadW	729	722	94.32	gadW.l6.c30.ctg.1	848	16.5	0	.	p	.	0	Q21H	NONSYN	61	63	CAA	54	56	CAT	5;4;4	C;A;T	5;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	264	gadW	729	722	94.32	gadW.l6.c30.ctg.1	848	16.5	0	.	p	.	0	L31V	NONSYN	91	93	CTG	84	86	GTG	5;5;5	G;T;G	5;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	264	gadW	729	722	94.32	gadW.l6.c30.ctg.1	848	16.5	0	.	p	.	0	D34E	NONSYN	100	102	GAT	93	95	GAG	5;5;5	G;A;G	5;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	264	gadW	729	722	94.32	gadW.l6.c30.ctg.1	848	16.5	0	.	p	.	0	L46P	NONSYN	136	138	CTG	129	131	CCG	2;2;2	C;C;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	264	gadW	729	722	94.32	gadW.l6.c30.ctg.1	848	16.5	0	.	p	.	0	E54D	NONSYN	160	162	GAA	153	155	GAT	2;5;5	G;A;T	2;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	264	gadW	729	722	94.32	gadW.l6.c30.ctg.1	848	16.5	0	.	p	.	0	I88M	NONSYN	262	264	ATA	255	257	ATG	9;9;9	A;T;G	9;9;9	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	264	gadW	729	722	94.32	gadW.l6.c30.ctg.1	848	16.5	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	258	260	CCG	9;9;9	C;C;G	9;9;9	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	264	gadW	729	722	94.32	gadW.l6.c30.ctg.1	848	16.5	0	.	p	.	0	D100E	NONSYN	298	300	GAC	291	293	GAA	2;2;3	G;A;A	2;2;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	264	gadW	729	722	94.32	gadW.l6.c30.ctg.1	848	16.5	0	.	p	.	0	P101S	NONSYN	301	303	CCC	294	296	TCC	3;3;3	T;C;C	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	264	gadW	729	722	94.32	gadW.l6.c30.ctg.1	848	16.5	0	.	p	.	0	R102G	NONSYN	304	306	CGG	297	299	GGG	3;3;3	G;G;G	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	264	gadW	729	722	94.32	gadW.l6.c30.ctg.1	848	16.5	0	.	p	.	0	K110N	NONSYN	328	330	AAA	321	323	AAT	11;11;12	A;A;T	11;11;12	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	264	gadW	729	722	94.32	gadW.l6.c30.ctg.1	848	16.5	0	.	p	.	0	S234A	NONSYN	700	702	TCG	693	695	GCG	22;21;20	G;C;G	21;21;20	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1038	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1365	40.7	0	.	p	.	0	F53L	NONSYN	157	159	TTC	447	449	TTA	45;44;43	T;T;A	45;43;43	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1038	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1365	40.7	0	.	p	.	0	V79I	NONSYN	235	237	GTT	525	527	ATT	35;35;35	A;T;T	35;35;35	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1038	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1365	40.7	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1026	1028	GGA	42;41;42	G;G;A	42;40;41	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1038	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1365	40.7	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1032	1034	CCG	32;32;32	C;C;G	32;32;31	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3648	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3179	61.5	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2306	2308	GAA	60;62;62	G;A;A	60;61;62	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3648	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3179	61.5	1	SNP	p	S83I	0	.	.	247	249	TCG	521	523	TCG	84;84;88	T;C;G	83;84;88	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3648	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3179	61.5	1	SNP	p	S83L	0	.	.	247	249	TCG	521	523	TCG	84;84;88	T;C;G	83;84;88	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3648	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3179	61.5	1	SNP	p	S83W	0	.	.	247	249	TCG	521	523	TCG	84;84;88	T;C;G	83;84;88	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3648	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3179	61.5	1	SNP	p	D87H	0	.	.	259	261	GAC	533	535	GAC	79;80;81	G,A;A;C	77,1;78;81	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3648	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3179	61.5	1	SNP	p	D87V	0	.	.	259	261	GAC	533	535	GAC	79;80;81	G,A;A;C	77,1;78;81	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3648	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3179	61.5	1	SNP	p	D87Y	0	.	.	259	261	GAC	533	535	GAC	79;80;81	G,A;A;C	77,1;78;81	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3648	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3179	61.5	1	SNP	p	D87G	0	.	.	259	261	GAC	533	535	GAC	79;80;81	G,A;A;C	77,1;78;81	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3648	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3179	61.5	1	SNP	p	D87N	0	.	.	259	261	GAC	533	535	GAC	79;80;81	G,A;A;C	77,1;78;81	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3380	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	3050	59.4	1	SNP	p	R136I	0	.	.	406	408	CGC	738	740	CGC	77;77;77	C;G;C	76;77;74	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3380	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	3050	59.4	1	SNP	p	R136G	0	.	.	406	408	CGC	738	740	CGC	77;77;77	C;G;C	76;77;74	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3380	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	3050	59.4	1	SNP	p	R136E	0	.	.	406	408	CGC	738	740	CGC	77;77;77	C;G;C	76;77;74	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3380	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	3050	59.4	1	SNP	p	R136C	0	.	.	406	408	CGC	738	740	CGC	77;77;77	C;G;C	76;77;74	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3380	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	3050	59.4	1	SNP	p	R136H	0	.	.	406	408	CGC	738	740	CGC	77;77;77	C;G;C	76;77;74	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3380	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	3050	59.4	1	SNP	p	R136S	0	.	.	406	408	CGC	738	740	CGC	77;77;77	C;G;C	76;77;74	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3380	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	3050	59.4	1	SNP	p	R136L	0	.	.	406	408	CGC	738	740	CGC	77;77;77	C;G;C	76;77;74	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	856	kdpE	678	678	98.23	kdpE.l15.c17.ctg.1	1086	41.7	0	.	p	.	0	A72P	NONSYN	214	216	GCG	423	425	CCG	57;54;56	C;C;G	55;54;56	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	856	kdpE	678	678	98.23	kdpE.l15.c17.ctg.1	1086	41.7	0	.	p	.	0	T123A	NONSYN	367	369	ACC	576	578	GCC	38;38;38	G;C;C	38;38;38	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1334	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1595	44.8	0	.	p	.	0	P9S	NONSYN	25	27	CCA	330	332	TCA	22;23;25	T;C;A	22;23;25	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	618	marA	384	384	99.74	marA.l15.c30.ctg.1	1021	32.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	418	marR	435	435	97.7	marR.l15.c4.ctg.1	928	23.9	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	601	603	AGC	23;23;23	A;G;C	23;23;23	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	418	marR	435	435	97.7	marR.l15.c4.ctg.1	928	23.9	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	703	705	CAT	10;8;8	C;A;T	10;7;8	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	418	marR	435	435	97.7	marR.l15.c4.ctg.1	928	23.9	1	SNP	p	V45E	0	.	.	133	135	GTG	427	429	GTG	53;53;54	G;T;G	53;53;54	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	418	marR	435	435	97.7	marR.l15.c4.ctg.1	928	23.9	1	SNP	p	I49S	0	.	.	145	147	ATC	439	441	ATC	58;57;57	A;T;C	58;57;57	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	418	marR	435	435	97.7	marR.l15.c4.ctg.1	928	23.9	1	SNP	p	A70T	0	.	.	208	210	GCA	502	504	GCA	54;53;53	G;C;A	53;53;53	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	418	marR	435	435	97.7	marR.l15.c4.ctg.1	928	23.9	1	SNP	p	R73S	0	.	.	217	219	CGT	511	513	CGT	45;42;42	C;G;T	44;42;42	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	418	marR	435	435	97.7	marR.l15.c4.ctg.1	928	23.9	1	SNP	p	R73C	0	.	.	217	219	CGT	511	513	CGT	45;42;42	C;G;T	44;42;42	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	418	marR	435	435	97.7	marR.l15.c4.ctg.1	928	23.9	1	SNP	p	R77L	0	.	.	229	231	CGC	523	525	CGC	41;42;42	C;G;C	41;41;42	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	418	marR	435	435	97.7	marR.l15.c4.ctg.1	928	23.9	1	SNP	p	R77C	0	.	.	229	231	CGC	523	525	CGC	41;42;42	C;G;C	41;41;42	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	418	marR	435	435	97.7	marR.l15.c4.ctg.1	928	23.9	1	SNP	p	L78M	0	.	.	232	234	CTG	526	528	CTG	43;42;40	C;T,C;G	43;41,1;40	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	418	marR	435	435	97.7	marR.l15.c4.ctg.1	928	23.9	1	SNP	p	R94H	0	.	.	280	282	CGC	574	576	CGC	20;21;21	C;G;C	20;21;21	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	418	marR	435	435	97.7	marR.l15.c4.ctg.1	928	23.9	1	SNP	p	R94S	0	.	.	280	282	CGC	574	576	CGC	20;21;21	C;G;C	20;21;21	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	418	marR	435	435	97.7	marR.l15.c4.ctg.1	928	23.9	1	SNP	p	V96E	0	.	.	286	288	GTA	580	582	GTA	20;20;20	G;T;A	20;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1262	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1745	38.8	0	.	p	.	0	S7F	NONSYN	19	21	TCC	276	278	TTC	14;14;14	T;T;C	14;13;14	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1262	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1745	38.8	0	.	p	.	0	R36I	NONSYN	106	108	AGG	363	365	ATC	25;24;22	A;T;C	25;24;22	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1262	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1745	38.8	0	.	p	.	0	E42A	NONSYN	124	126	GAA	381	383	GCC	11;12;12	G;C;C	11;12;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1262	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1745	38.8	0	.	p	.	0	N43V	NONSYN	127	129	AAT	384	386	GTG	12;12;12	G;T;G	12;12;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1262	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1745	38.8	0	.	p	.	0	E52D	NONSYN	154	156	GAG	411	413	GAT	23;22;21	G;A;T	23;22;21	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1262	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1745	38.8	0	.	p	.	0	N59T	NONSYN	175	177	AAC	432	434	ACC	26;26;25	A;C;C	26;26;25	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1262	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1745	38.8	0	.	p	.	0	I68L	NONSYN	202	204	ATA	459	461	TTA	28;27;24	T;T;A	28;27;24	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1262	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1745	38.8	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	600	602	CAG	61;60;60	C;A;G	61;60;60	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1262	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1745	38.8	0	.	p	.	0	D128A	NONSYN	382	384	GAC	639	641	GCC	50;48;49	G;C;C	50;48;49	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1262	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1745	38.8	0	.	p	.	0	S163A	NONSYN	487	489	TCG	744	746	GCG	49;52;49	G;C;G	49;52;49	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1262	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1745	38.8	0	.	p	.	0	L231V	NONSYN	691	693	CTT	948	950	GTT	36;35;34	G;T;T	26;32;34	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1262	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1745	38.8	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1110	1110	C	47	C	47	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1270	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1633	41.5	0	.	p	.	0	V12trunc	TRUNC	34	34	G	216	216	G	45	G	45	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1270	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1633	41.5	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	273	275	CAG	31;32;32	C;A;G	31;32;32	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1270	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1633	41.5	0	.	p	.	0	T83I	NONSYN	247	249	ACC	423	425	ATC	45;44;43	A;T;C	45;44;43	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1270	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1633	41.5	0	.	p	.	0	I99M	NONSYN	295	297	ATA	471	473	ATG	23;22;24	A;T;G	22;22;23	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1270	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1633	41.5	0	.	p	.	0	A130T	NONSYN	388	390	GCC	564	566	ACC	44;45;44	A;C;C	44;45;44	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1270	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1633	41.5	0	.	p	.	0	P257T	NONSYN	769	771	CCG	945	947	ACG	59;60;60	A;C;G	57;59;59	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3782	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3709	54.7	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2019	2021	ACC	56;56;55	A;C;C	56;56;55	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3782	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3709	54.7	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2412	2414	CAA	54;52;51	C;A;A	52;47;49	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3782	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3709	54.7	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2580	2582	ATT	48;49;48	A;T;T	48;49;48	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3782	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3709	54.7	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2664	2666	GTT	50;48;51	G;T;T	50;48;51	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3782	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3709	54.7	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2772	2774	GAG	53;50;49	G;A;G	53;50;49	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3782	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3709	54.7	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3000	3002	ATG	41;41;41	A;T;G	41;41;41	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3782	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3709	54.7	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3135	3137	GAT	39;40;45	G;A;T	39;38;44	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3550	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3636	52.3	0	.	p	.	0	I46M	NONSYN	136	138	ATC	398	400	ATG	37;38;38	A;T;G	36;37;37	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3550	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3636	52.3	0	.	p	.	0	V208I	NONSYN	622	624	GTC	884	886	ATC	63;61;59	A;T;C	63;60;59	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3550	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3636	52.3	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3200	3202	CAC	17;18;19	C;A;C	17;17;17	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3550	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3636	52.3	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3203	3205	CTC	17;17;17	C;T;C	17;17;16	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1676	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1976	45.4	0	.	p	.	0	D3E	NONSYN	7	9	GAT	266	268	GAA	42;42;42	G;A;A	42;42;42	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1676	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1976	45.4	0	.	p	.	0	T226A	NONSYN	676	678	ACG	935	937	GCG	50;51;51	G;C;G	50;50;51	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1676	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1976	45.4	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1277	1279	ATC	53;52;53	A;T;C	51;51;53	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1676	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1976	45.4	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1580	1582	TTT	64;64;63	T;T;T	64;63;63	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1794	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1783	53.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4448	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3795	62.8	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1278	1280	ACC	60;60;62	A;C;C	59;56;62	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4448	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3795	62.8	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2520	2522	GAC	69;67;68	G;A;C	69;67;68	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1898	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1681	50.5	0	.	p	.	0	V200I	NONSYN	598	600	GTC	746	748	ATC	57;57;59	A;T;C	57;57;59	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1898	mdtG	1227	182	99.45	mdtG.l15.c30.ctg.2	508	28.4	0	.	p	.	0	E5G	NONSYN	13	15	GAA	117	119	GGA	20;23;26	G;G;A	20;23;26	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1352	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1798	40.4	0	.	p	.	0	G134C	NONSYN	400	402	GGT	727	729	TGT	44;43;42	T;G;T	44;43;42	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1352	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1798	40.4	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1297	1299	TTG	39;39;40	T;T;G	39;39;39	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1352	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1798	40.4	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1507	1509	ACG	18;18;19	A;C;G	17;18;19	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1770	mdtL	1176	1176	98.38	mdtL.l15.c30.ctg.1	1840	51.8	0	.	p	.	0	A185S	NONSYN	553	555	GCC	866	868	TCC	55;55;56	T;C;C	51;54;55	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	1406	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1623	46.3	0	.	p	.	0	V119I	NONSYN	355	357	GTT	618	620	ATT	41;44;45	A;T;T	41;44;45	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2538	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2543	53.5	0	.	p	.	0	V11M	NONSYN	31	33	GTG	183	185	ATG	31;32;32	A;T;G	31;31;32	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2538	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2543	53.5	0	.	p	.	0	T33I	NONSYN	97	99	ACC	249	251	ATC	33;33;33	A;T,C;C	32;31,1;32	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2538	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2543	53.5	0	.	p	.	0	C116R	NONSYN	346	348	TGC	498	500	CGC	51;51;48	C;G;C	51;51;48	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2538	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2543	53.5	0	.	p	.	0	N238S	NONSYN	712	714	AAC	864	866	AGC	51;50;50	A;G;C	50;48;50	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2538	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2543	53.5	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1065	1067	GTG	52;51;52	G;T;G	51;47;51	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2538	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2543	53.5	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1128	1130	AAC	29;28;30	A;A;C	27;24;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2538	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2543	53.5	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1173	1175	GTC	51;51;52	G,A;T;C	50,1;50;52	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2538	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2543	53.5	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1203	1205	ATA	64;63;62	A;T;A	64;62;62	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2538	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2543	53.5	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1311	1313	TCT	55;55;55	T;C;T	55;55;55	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2538	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2543	53.5	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1698	1700	GCG	66;67;68	G;C;G	65;66;67	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2538	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2543	53.5	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1911	1913	ATC	53;51;50	A;T;C	52;51;50	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1756	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2086	45.2	0	.	p	.	0	S129A	NONSYN	385	387	TCA	678	680	GCG	62;63;66	G;C;G	61;63;66	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1756	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2086	45.2	0	.	p	.	0	A187T	NONSYN	559	561	GCC	852	854	ACC	51;52;53	A;C;C	51;52;53	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1756	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2086	45.2	0	.	p	.	0	H211R	NONSYN	631	633	CAC	924	926	CGC	55;54;56	C;G;C	55;54;56	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1756	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2086	45.2	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1041	1043	GCT	45;46;44	G;C;T	45;45;44	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1756	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2086	45.2	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1125	1127	AAA	40;40;39	A;A;A	40;40;39	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1756	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2086	45.2	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1143	1145	CGA	33;34;35	C;G;A	33;33;35	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1756	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2086	45.2	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1308	1310	GCC	46;48;49	G;C;C	46;48;49	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1756	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2086	45.2	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1320	1322	GAT	50;53;54	G;A;T	50;53;54	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1756	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2086	45.2	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1737	1739	GCT	33;32;30	G;C;T	31;32;30	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	4250	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	4080	56.0	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1603	1605	AAG	42;41;41	A;A;G	42;41;41	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	4250	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	4080	56.0	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2680	2682	CTG	57;56;54	C;T;G	57;53;54	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	288	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	711	21.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2408	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2339	55.3	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1049	1051	AAC	63;63;66	A;A;C	62;60;64	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2408	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2339	55.3	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1595	1597	ATA	65;64;64	A;T;A	65;64;64	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1796	murA_12	1260	1260	98.49	murA_12.l6.c30.ctg.1	1883	51.2	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1416	1418	GAT	80;84;87	G;A;T,A	79;83;85,1	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1796	murA_12	1260	1260	98.49	murA_12.l6.c30.ctg.1	1883	51.2	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1419	1421	CTG	82;83;81	C;T;G	82;83;80	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	992	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1272	41.7	0	.	p	.	0	R27C	NONSYN	79	81	CGT	368	370	TGT	29;30;31	T;G;T	29;30;31	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	992	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1272	41.7	0	.	p	.	0	I117T	NONSYN	349	351	ATC	638	640	ACC	69;67;67	A;C;C	67;66;67	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	992	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1272	41.7	0	.	p	.	0	G187D	NONSYN	559	561	GGC	848	850	GAC	70;69;71	G;A;C	70;69;71	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	992	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1272	41.7	1	SNP	p	R15C	0	.	.	43	45	CGC	332	334	CGC	70;68;67	C,A;G;C	69,1;68;66	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	992	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1272	41.7	1	SNP	p	S33R	0	.	.	97	99	AGC	386	388	AGC	34;33;35	A;G;C	34;33;35	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	992	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1272	41.7	1	SNP	p	G131D	0	.	.	391	393	GGC	680	682	GGC	54;53;53	G;G;C	54;51;48	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	992	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1272	41.7	1	SNP	p	R203C	0	.	.	607	609	CGT	896	898	CGT	69;71;71	C;G;T	69;71;71	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	992	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1272	41.7	1	SNP	p	R203L	0	.	.	607	609	CGT	896	898	CGT	69;71;71	C;G;T	69;71;71	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1856	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1606	61.5	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1241	1243	GAG	76;76;75	G;A;G	76;75;74	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1856	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1606	61.5	1	SNP	p	G141D	0	.	.	421	423	GGT	728	730	GGT	76;79;78	G;G;T	76;79;78	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1856	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1606	61.5	1	SNP	p	G141E	0	.	.	421	423	GGT	728	730	GGT	76;79;78	G;G;T	76;79;78	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1856	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1606	61.5	1	SNP	p	R154A	0	.	.	460	462	CGT	767	769	CGT	93;94;96	C;G;T	92;94;96	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1856	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1606	61.5	1	SNP	p	R154D	0	.	.	460	462	CGT	767	769	CGT	93;94;96	C;G;T	92;94;96	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3296	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2916	60.6	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1913	1915	GTG	86;85;86	G;T;G	86;85;85	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3296	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2916	60.6	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1940	1942	TCG	87;89;93	T;C;G	81;85;90	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3296	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2916	60.6	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2555	2557	AAC	43;44;43	A;A;C	42;44;43	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3296	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2916	60.6	1	SNP	p	A85T	0	.	.	253	255	GCG	569	571	GCG	62;62;61	G;C;G	62;62;61	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3296	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2916	60.6	1	SNP	p	D111H	0	.	.	331	333	GAT	647	649	GAT	57;57;57	G;A;T	57;57;55	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3296	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2916	60.6	1	SNP	p	S129P	0	.	.	385	387	TCC	701	703	TCC	75;74;75	T;C;C,A	72;72;74,1	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	2214	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2464	48.1	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1712	1714	AAC	61;60;60	A;A;C	61;60;60	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	2214	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2464	48.1	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1721	1723	GAT	66;63;61	G;A;T	66;63;61	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	2152	patA	1380	1380	99.78	patA.l15.c30.ctg.1	2137	54.0	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	1020	1022	CAG	57;57;62	C;A,C;G	57;56,1;61	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	2152	patA	1380	1380	99.78	patA.l15.c30.ctg.1	2137	54.0	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1494	1496	GAT	74;75;76	G;A;T	74;74;76	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6284	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4683	72.1	1	SNP	p	V146F	0	.	.	436	438	GTT	728	730	GTT	90;88;89	G;T;T	90;88;89	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6284	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4683	72.1	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1829	1831	CAG	75;77;77	C;A;G	75;76;76	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6284	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4683	72.1	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1829	1831	CAG	75;77;77	C;A;G	75;76;76	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6284	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4683	72.1	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1868	1870	CAC	74;74;73	C;A;C,T	74;74;71,1	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6284	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4683	72.1	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1877	1879	CGT	65;64;64	C;G;T	65;64;63	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6284	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4683	72.1	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1877	1879	CGT	65;64;64	C;G;T	65;64;63	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6284	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4683	72.1	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1883	1885	TCC	62;60;60	T;C;C	62;58;60	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6284	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4683	72.1	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1889	1891	CTC	62;61;60	C;T;C	62;60;60	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6284	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4683	72.1	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1979	1981	ACC	89;87;86	A;C;C	86;87;86	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6284	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4683	72.1	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1982	1984	CCT	87;89;89	C;C;T	86;89;87	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6284	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4683	72.1	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2351	2353	CGT	67;65;65	C;G;T	66;65;64	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	0	.	n	.	0	A226G	SNP	226	226	A	253	253	G	589	G	586	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	1	SNP	n	A794G	0	.	.	794	794	A	821	821	A	552	A,C	544,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	1	SNP	n	A794T	0	.	.	794	794	A	821	821	A	552	A,C	544,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	1	SNP	n	G926A	0	.	.	926	926	G	953	953	G	535	G	533	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	1	SNP	n	G926C	0	.	.	926	926	G	953	953	G	535	G	533	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	1	SNP	n	G926T	0	.	.	926	926	G	953	953	G	535	G	533	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	0	HET	.	.	.	A79G	.	79	79	A	106	106	A	562	A,G	402,153	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	0	HET	.	.	.	C719T	.	719	719	C	746	746	C	508	C,T	293,212	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	0	HET	.	.	.	T273A	.	273	273	T	300	300	T	500	T,A	365,126	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	0	HET	.	.	.	C183T,A	.	183	183	C	210	210	C	553	C,T,A	368,182,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	0	HET	.	.	.	A250T	.	250	250	A	277	277	A	538	A,T	407,128	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	0	HET	.	.	.	T90C	.	90	90	T	117	117	T	555	T,C	398,151	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	0	HET	.	.	.	G474A	.	474	474	G	501	501	G	570	G,A	449,118	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	0	HET	.	.	.	A253T	.	253	253	A	280	280	A	538	A,T	410,125	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	0	HET	.	.	.	G895A	.	895	895	G	922	922	G	471	G,A	403,65	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	543.2	0	HET	.	.	.	C194T	.	194	194	C	221	221	C	590	C,T	468,119	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	516	543.7	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	533	A,C	524,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	516	543.7	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	533	A,C	524,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	516	543.7	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	533	A,C	524,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	140	95.04	rrsB+.l15.c30.ctg.4	140	115.8	0	.	n	.	0	G1002A	SNP	1002	1002	G	54	54	A	203	A	203	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	140	95.04	rrsB+.l15.c30.ctg.4	140	115.8	0	.	n	.	0	G1006C	SNP	1006	1006	G	58	58	C	205	C	205	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	140	95.04	rrsB+.l15.c30.ctg.4	140	115.8	0	.	n	.	0	T1010C	SNP	1010	1010	T	62	62	C	205	C	205	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	140	95.04	rrsB+.l15.c30.ctg.4	140	115.8	0	.	n	.	0	A1019.	DEL	1019	1019	A	70	70	G	208	G	208	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	140	95.04	rrsB+.l15.c30.ctg.4	140	115.8	0	.	n	.	0	.1023G	INS	1023	1023	T	75	75	G	219	G	219	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	140	95.04	rrsB+.l15.c30.ctg.4	140	115.8	0	.	n	.	0	C1038T	SNP	1038	1038	C	90	90	T	188	T	187	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	18162	rrsB+	1542	142	100.0	rrsB+.l15.c30.ctg.5	142	146.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	1016	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	1246	43.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	822	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1009	43.6	1	SNP	p	R20H	0	.	.	58	60	CGC	358	360	CGC	64;66;67	C;G;C	64;66;65	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	822	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1009	43.6	1	SNP	p	G121D	0	.	.	361	363	GGT	661	663	GGT	60;60;59	G;G;T	60;60;58	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	730	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	1026	38.2	1	SNP	p	A12S	0	.	.	34	36	GCA	379	381	GCA	112;113;115	G;C;A	112;113;115	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	2052	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c4.ctg.1	1438	76.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	1920	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c30.ctg.1	1508	68.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.3000412.AY055428.20268_21084.552	sul2.3000412.AY055428.20268_21084.552	1	0	539	1598	sul2	816	816	99.88	sul2.l15.c30.ctg.1	1544	55.4	0	.	p	.	0	A136S	NONSYN	406	408	GCA	747	749	TCA	95;96;99	T;C;A	92;96;98	.	Sul2 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria, usually found on small plasmids.;sul2
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	2420	tetA	1200	1200	100.0	tetA.l15.c4.ctg.1	1691	76.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	1334	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1242	57.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	2292	tolC	1488	1488	98.72	tolC.l6.c4.ctg.1	2168	56.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
